Tuesday, November 12, 2019

Finch Therapeutics Taps into the Human Microbiome to Find Disease Causes and Cures

Finch Therapeutics is developing microbial therapies designed to alter the microbiome for treatment of patients suffering from diseases as varied as bacterial infections and autism. In 2019, the company received a Breakthrough Therapy designation from the US Food and Drug Administration (FDA)...

Blaze Bioscience Shines a Light on Tumor Cells to Guide Pediatric Brain Cancer Surgeons

Blaze Bioscience is literally lighting the way for cancer surgeons to remove children’s brain tumors without harming their healthy neural tissues. The company is developing drugs that use optimized CDPs, also called cystine-dense miniproteins, derived from natural organisms such...

Oncternal Therapeutics Pursuing Novel Treatment for Ewing Sarcoma in Challenging Field of Pediatric Cancer

The WuXi AppTec Communications team is excited to kick-off a new series on pediatric cancer that highlights companies seeking novel therapies for children, long a challenging space. Drug development advances in the last decade have produced new treatments for many diseases. However, since most of those...

Redefining Therapeutics Through Control of Gene Expression, a Conversation with Nancy Simonian, M.D., President and CEO, Syros Pharmaceuticals

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) and the WuXi AppTec Content Team Drug development is a very risky business. For more than 20 years, Nancy Simonian, an accomplished veteran drug developer (having served as...

Kymera’s Next Generation Therapeutics: Protein Degraders. New Way and New Rules for a New Modality.

By Rich Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) and WuXi AppTec Content Team Proteins are essential to proper cellular function. Protein dysfunction, arising from any number of causes, can lead to serious diseases. It is often...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide...

November 11, 2019: WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and...